home / stock / inmd / inmd news


INMD News and Press, InMode Ltd. From 04/29/22

Stock Information

Company Name: InMode Ltd.
Stock Symbol: INMD
Market: NYSE
Website: inmodemd.com

Menu

INMD INMD Quote INMD Short INMD News INMD Articles INMD Message Board
Get INMD Alerts

News, Short Squeeze, Breakout and More Instantly...

INMD - Notable earnings before Monday's open

AMG,ARLP,AUDC,AXSM,AYRO,BKCC,BRK.B,CNA,CRNT,EPD,GLMD,GPN,GPRE,INMD,ITRI,L,MCO,NGD,ON,PK,SAIA,SIX,SXC,TKR,WEC For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings before Monday's open

INMD - OMIC, CTMX and LFST among after hour movers

Gainers:Singular Genomics Systems  (OMIC) +5%. Sonos  (SONO) +5%. Fulton Financial Corporation (FULT) +5%. CytomX Therapeutics (CTMX) +5%. Walgreens Boots Alliance (WBA) +4%. Losers: Netflix (NFLX) -26%. LifeStance Health Group (LFST) -8%. INMODE  (INMD) -8%. Rok...

INMD - 3 Growth Stocks That Will Beat Cathie Wood's Ark Innovation ETF This Year

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Xpeng ( XPEV ) is growing rapidly, and its EVs are very strong technologically. Stem’s ( STEM ) sales are rapidly increasing, and it is getting a boost from the renewable energy revolution. InMode&#...

INMD - Hot Stocks: SAIL takeover deal; INMD hits low; VERU jumps on clinical data; ZNTL falls

Wall Street posted another day of losses on Monday, as technology retreated and volatility jumped. The Nasdaq led the decline, falling more than 2% on the session. Clinical trial data decided the fates of a couple of drug developers during the session. Veru (VERU) nearly tripled amid positive...

INMD - InMode reports 1Q22 prelim revenue and Adj. EPS above the consensus

InMode (NASDAQ:INMD) expects 1Q22 revenue in the range of $85M to $85.5M vs consensus of $80.23M. Non-GAAP earnings per diluted share expected in the range of $0.38 to $0.39 vs consensus of $0.36. Non-GAAP gross margin for the first quarter of 2022 in the range o...

INMD - InMode slips despite better-than-expected projections for Q1

The shares of healthcare equipment maker, InMode (NASDAQ:INMD) are trading lower for the third straight session despite setting its preliminary financials for 1Q 2022 ahead of the consensus on Monday. Based on the early financial results, InMode (INMD) projects its 1Q 2022 revenue and non-GAA...

INMD - InMode Expects First Quarter 2022 Revenue Between $85.0-$85.5M, Non-GAAP Earnings per Diluted Share Between $0.38-$0.39

InMode Expects First Quarter 2022 Revenue Between $85.0-$85.5M, Non-GAAP Earnings per Diluted Share Between $0.38-$0.39 PR Newswire Conference call to be held on Monday, May 2, 2022 , at 8:30 a.m. Eastern Time YOKNEAM, Israel, April 11, 2022 /PRNewswire/ ...

INMD - 3 Under-the-Radar Biotech Stocks That Will Zoom Higher

This a great market for stock pickers. Multiples have been cut in half for a lot of small-caps as the stock market has no appetite for risk right now. Nonetheless, if you do a lot of digging, you can find stocks with remarkable upside. Here's why our roundtable likes Affimed (NASD...

INMD - InMode to Participate Virtually in a Fireside Chat at the 21st Annual Needham Healthcare Conference

InMode to Participate Virtually in a Fireside Chat at the 21st Annual Needham Healthcare Conference PR Newswire YOKNEAM, Israel , April 5, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today ann...

INMD - InMode Stock: A Good Buy The Dip Opportunity

The steep decline in INMD has been a great opportunity for investors with a longer time horizon to increase their potential returns by buying the dip. The current disconnect between the business and the stock creates a great buying opportunity for risk tolerant investors. The US, ...

Previous 10 Next 10